Bob Saget, Michael Che, Andy Cohen, John Oliver, Jeff Ross, and Musical Guest Jackson Browne Along with Top Chef Masters Bring "Cool Comedy - Hot Cuisine" to New York on December 11th

LOS ANGELES, Nov. 1, 2018 /PRNewswire/ -- Bob Saget will host Cool Comedy – Hot Cuisine, in New York to benefit the Scleroderma Research Foundation (SRF) on, Tuesday, December 11th at Carolines on Broadway. Saget, an SRF Board Member who lost his sister to scleroderma, will be joined in the fundraising effort for this life-threatening disease with appearances by Michael Che, Andy Cohen, John Oliver, Jeff Ross, and musical guest Jackson Browne.

Presented by Actelion Pharmaceuticals and the Arthur Zimtbaum Foundation, Cool Comedy – Hot Cuisine will celebrate over 30 years of history and achievements by the Scleroderma Research Foundation—America's first and leading nonprofit investor in medical research to find improved therapies and a cure for people living with scleroderma. The "Hot Cuisine" for the evening will be provided by celebrity chefs and restaurateurs, Susan Feniger, who is an SRF Board Member, and her business partner, Mary Sue Milliken (Food Network's Too Hot Tamales and Bravo's Top Chef Masters). The renowned chefs will treat guests to a multi-course dinner with dishes from their highly acclaimed Border Grill Restaurants.

Since its founding in 1987 by patient and advocate Sharon Monsky, the SRF has raised over $47 million, and was recently named one of the Top 10 Medical Research Foundations in the country by Charity Navigator. The foundation has taken a collaborative approach to research, bringing together some of the brightest minds in science to unravel the mystery of this complex autoimmune disease. As best put by Monsky: "I could organize a support group to help people in my community living with scleroderma, or I could establish an organization that would bring the best of science and technology together in an effort to discover better treatments and a cure for people everywhere living with scleroderma. It wasn't easy, but I chose the latter." Sharon lost her battle to the disease in 2002, but her vision lives on today.

The success of Cool Comedy – Hot Cuisine events held in Los Angeles, San Francisco, Las Vegas and New York has raised considerable awareness for scleroderma and enabled the SRF to fund innovative research bringing hope and helping to improve the quality of life for patients suffering from this debilitating disease.

Cool Comedy – Hot Cuisine will include a cocktail reception, four-course dinner, stand-up comedy, and musical performance. The evening will also include live auction packages, as well as silent auction items, and new this year, a VIP after-party sponsored by Corbus Pharmaceuticals.

Individual tickets for Cool Comedy – Hot Cuisine start at $1000, and tiered tables start at $5000. Tickets to the VIP after-party are $100 each. All money raised will benefit scleroderma research, and more information about the event, including how to purchase tickets, can be found at srfcchc.org.

More about Scleroderma and the Scleroderma Research Foundation:

The word scleroderma literally means "hard skin," but the disease typically does much more than that, often affecting the internal organs with life-threatening consequences. In some cases, the joints and muscles are affected, resulting in severe pain and limited mobility. Vascular damage due to scleroderma can result in loss of fingers, toes and entire limbs. The symptoms and severity of scleroderma vary from one patient to another, and the course of the disease is often unpredictable. The disease usually effects women–who represent four out of every five patients–between the ages of 30 and 50; however, children and men of all ages and across all ethnic boundaries can also be affected.

Today, there is still no cure for scleroderma. Treatments are available for some–though not all–of the most serious complications. However, with a research program led by a world-class Scientific Advisory Board, the SRF is providing new hope for patients. The continued success of the Scleroderma Research Foundation is entirely dependent upon charitable gifts from individuals and corporations. According to Dr. Fredrick Wigley, Director of the Johns Hopkins Scleroderma Center, in Project Scleroderma, "the SRF has made an incredible difference, and I am absolutely convinced with the right support there is nothing that can't be done."

Chaired by Dr. Luke Evnin, managing partner of MPM Capital and dedicated investor in life sciences, the Foundation is enabling scientists from leading institutions across the nation and around the world to work together and develop an understanding of how the disease begins, progresses, and what can be done to slow, halt or reverse the disease process. For more information, call +1 (415) 834 9444 or visit www.srfcure.org.

SOURCE Scleroderma Research Foundation